Venlafaxine Hydrochloride SR (WW) Pellets
Rraynex supplies Venlafaxine Hydrochloride SR (WW) Pellets as sustained-release pellets in the SNRI Antidepressant category, in a strength of 50%.
Product overview
Venlafaxine is an SNRI antidepressant; extended-release pellet capsules allow once-daily dosing.
Pharmaceutical pellets are small, free-flowing spherical units filled into capsules or compressed into MUPS tablets. Dividing a dose across many pellets gives more reproducible gastric transit and release than a single-unit tablet.
Formulation and release profile
Sustained-release (SR) pellets release the drug gradually through a release-controlling coat or matrix, flattening plasma peaks and reducing dosing frequency.
Pharmaceutical applications
- Capsule filling of venlafaxine hydrochloride sr (ww) pellets for antidepressant products.
- Multiparticulate dosage forms where reproducible release matters.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Venlafaxine Hydrochloride SR (WW) Pellets
- Form
- sustained-release Pellets
- Therapeutic category
- SNRI Antidepressant
- Strength
- 50%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Venlafaxine Hydrochloride SR (WW) Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Venlafaxine products from Rraynex
- Venlafaxine HCl — Pellets